(Q58005087)
Statements
Dosimetry for fractionated (131)I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results (English)
Sarah Chittenden
Mike Partridge
Donna Lancaster
Andrew Pearson
Susan E Buckley